Boehringer Ingelheim Animal Health USA, Inc. today announced Daniel Watkins as the new leader of the company's U.S. Pets business. Watkins, who previously was the head of Boehringer Ingelheim’s Australia and New Zealand Animal Health business, will be responsible for advancing the company’s pet health leadership in the United States, with an emphasis in bringing innovative new products to market for pets and the people who care for them. Watkins begins in his new role today and will be based out of the Boehringer Ingelheim Animal Health headquarters in Duluth, Georgia.

“We are thrilled to welcome Daniel back home to the U.S. to lead our Pet business here during a pivotal time,” said Randolph Legg, President and Head of Commercial Business, Boehringer Ingelheim Animal Health. “Daniel is a proven leader who achieves results by focusing on customer-centric strategies, team development, and a performance culture based on trust and collaboration. We have many milestones and new product launches in 2023, and Daniel’s vast experience in the pet health industry, coupled with his leadership skills and vision, make him the ideal person to lead us forward.”

Watkins joined Boehringer Ingelheim Animal Health USA, Inc. in 2012 in financial controlling and held roles at the company’s global headquarters in Ingelheim, Germany, before moving to Australia. Prior to joining Boehringer Ingelheim, Watkins held various roles with retail brands including Hallmark Cards and Conagra Foods.

“At Boehringer Ingelheim Animal Health, we have an amazing responsibility in our commitment to improving the health and wellbeing of millions of pets and supporting the veterinarians who care for them,” said Watkins. “My family and I are excited to return to Georgia and for the opportunity to lead our U.S. Pet business forward.”